Related references
Note: Only part of the references are listed.Using medication-assisted treatment for substance use disorders: Evidence of barriers and facilitators of implementation
Paul M. Roman et al.
ADDICTIVE BEHAVIORS (2011)
Counselor attitudes toward the use of naltrexone in substance abuse treatment: A multi-level modeling approach
Amanda J. Abraham et al.
ADDICTIVE BEHAVIORS (2011)
Integrating Addiction Medicine Into Graduate Medical Education in Primary Care: The Time Has Come
Patrick G. O'Connor et al.
ANNALS OF INTERNAL MEDICINE (2011)
Policy Implications of Integrating Buprenorphine/Naloxone Treatment and HIV Care
Ruth Finkelstein et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)
Adoption and Implementation of Medications in Addiction Treatment Programs
Hannah K. Knudsen et al.
JOURNAL OF ADDICTION MEDICINE (2011)
Buprenorphine Clinic for Opioid Maintenance Therapy: Program Description, Process Measures, and Patient Satisfaction
Stephen Strobbe et al.
JOURNAL OF ADDICTIONS NURSING (2011)
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Substance Use and Related Disorders. Part 2: Opioid dependence
Michael Soyka et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2011)
Barriers to Opioid Substitution Treatment Access, Entry and Retention: A Survey of Opioid Users, Patients in Treatment, and Treating and Non-Treating Physicians
Heino Stoever
EUROPEAN ADDICTION RESEARCH (2011)
Efficacy and Tolerability of Naltrexone in the Management of Alcohol Dependence
James C. Garbutt
CURRENT PHARMACEUTICAL DESIGN (2010)
Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan
Dennis McCarty et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
The pharmacological treatment of opioid addiction-a clinical perspective
Philipp Lobmaier et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Psychiatrist Characteristics That Influence Use of Buprenorphine Medication-Assisted Treatment
Joann Albright et al.
JOURNAL OF ADDICTION MEDICINE (2010)
Facilitating Factors and Barriers to the Use of Medications in Publicly Funded Addiction Treatment Organizations
Hannah K. Knudsen et al.
JOURNAL OF ADDICTION MEDICINE (2010)
The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment
James E. Egan et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2010)
Pharmacotherapy of Alcohol Use Disorders in the Veterans Health Administration
Alex Harris et al.
PSYCHIATRIC SERVICES (2010)
Substance Abuse Treatment Organizations as Mediators of Social Policy: Slowing the Adoption of a Congressionally Approved Medication
Stanley S. Wallack et al.
JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH (2010)
Partnerships and pathways of dissemination: The National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network
Steve Martino et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2010)
Comparison of costs and utilization among buprenorphine and methadone patients
Paul G. Barnett
ADDICTION (2009)
Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty
Tami L. Mark et al.
DRUG AND ALCOHOL DEPENDENCE (2009)
Buprenorphine Prescribing: Why Physicians Aren't and Nurse Prescribers Can't
Katherine Fornili et al.
JOURNAL OF ADDICTIONS NURSING (2009)
Integrating Buprenorphine Treatment into Office-based Practice: a Qualitative Study
Declan T. Barry et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2009)
Counselor Attitudes Toward Pharmacotherapies for Alcohol Dependence
Amanda J. Abraham et al.
JOURNAL OF STUDIES ON ALCOHOL AND DRUGS (2009)
Alcohol and Global Health 1 Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
Juergen Rehm et al.
LANCET (2009)
Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network
Hannah K. Knudsen et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2009)
Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence
Gayle Ridge et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2009)
Factors affecting willingness to provide buprenorphine treatment
Julie Netherland et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2009)
Understanding Attitudes Toward Use of Medication in Substance Abuse Treatment: A Multilevel Approach
John Fitzgerald et al.
PSYCHOLOGICAL SERVICES (2009)
Physician Training is Never a Failure
Adam J. Gordon et al.
AMERICAN JOURNAL ON ADDICTIONS (2009)
What Explains the Diffusion of Treatments for Mental Illness?
Robert Drake et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Narrative review: Buprenorphine for opioid-dependent patients in office practice
Lynn E. Sullivan et al.
ANNALS OF INTERNAL MEDICINE (2008)
Opioid use disorder in the United States: Insurance status and treatment access
William C. Becker et al.
DRUG AND ALCOHOL DEPENDENCE (2008)
Office-based management of opioid dependence with buprenorphine: Clinical practices and barriers
Alexander Y. Walley et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2008)
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of substance use and related disorders, Part 1: Alcoholism
Michael Soyka et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2008)
The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: A Relative Benefits analysis of randomized controlled trials
James L. Snyder et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2008)
State policy influence on the early diffusion of buprenorphine in community treatment programs
Lori J. Ducharme et al.
SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY (2008)
Role of state policies in the adoption of naltrexone for substance abuse treatment
Carolyn J. Heinrich et al.
HEALTH SERVICES RESEARCH (2008)
Availability of addiction medications in private health plans
Constance M. Horgan et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2008)
Does following research-derived practice guidelines improve opiate-dependent patients' outcomes under everyday practice conditions? Results of the Multisite Opiate Substitution Treatment study
Keith Humphreys et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2008)
Acamprosate supports abstinence, Naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes
Susanne Roesner et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Outcomes of DATA 2000 Certification Trainings for the Provision of Buprenorphine Treatment in the Veterans Health Administration
Adam J. Gordon et al.
AMERICAN JOURNAL ON ADDICTIONS (2008)
Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians
Chinazo O. Cunningham et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2007)
The adoption of medications in substance abuse treatment: Associations with organizational characteristics and technology clusters
Hannah K. Knudsen et al.
DRUG AND ALCOHOL DEPENDENCE (2007)
Knowledge and attitudes about pharmacotherapy for alcoholism: A survey of counselors and administrators in community-based addiction treatment centres
Suzanne E. Thomas et al.
ALCOHOL AND ALCOHOLISM (2007)
Combined pharmacotherapies and behavioral interventions for alcohol dependence - The COMBINE study: A randomized controlled trial
RF Anton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence
BJ Turner et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Acamprosate for the treatment of alcohol dependence
LA Boothby et al.
CLINICAL THERAPEUTICS (2005)
Challenges to medications development in treating alcohol dependence: An international perspective - Summary of a symposium held at the ESBRA Congress, Prague, 13 September 2003
JM Littleton et al.
ALCOHOL AND ALCOHOLISM (2004)
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence:: a systematic review
B Carmen et al.
ADDICTION (2004)
Challenges in increasing access to buprenorphine treatment for opiate addiction
JC West et al.
AMERICAN JOURNAL ON ADDICTIONS (2004)
Barriers to the use of medications to treat alcoholism
TL Mark et al.
AMERICAN JOURNAL ON ADDICTIONS (2003)
Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients
RP Mattick et al.
ADDICTION (2003)
Research to practice: adoption of naltrexone in alcoholism treatment
CP Thomas et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2003)
Naltrexone, a relapse prevention maintenance treatment of alcohol dependence: A meta-analysis of randomized controlled trials
C Streeton et al.
ALCOHOL AND ALCOHOLISM (2001)
The cost-effectiveness of buprenorphine maintenance therapy for opiate addiction in the United States
PG Barnett et al.
ADDICTION (2001)
Office-based treatment for opioid dependence: Reaching new patient populations
DA Fiellin et al.
AMERICAN JOURNAL OF PSYCHIATRY (2001)